UM Submission Instructions: Pathway to Stop Diabetes 2025
Sponsor: |
American Diabetes Association (ADA),American Diabetes Association (ADA) |
Award Title: |
Pathway to Stop Diabetes |
Amount: |
$1.625 Million
Initiator Award:
Up to $100,000 USD per year in Phase 1, Up to $325,000 USD per year in Phase 2
Indirect Costs: Up to 10% of direct costs in Phase 1, Up to 30% of direct costs in Phase 2
Award Term: Up to 7 years
Accelerator Award:
Maximum Requested Budget: $325,000 per year
Indirect Costs: Up to 30%
Award Term - up to 5 years |
UM Deadline: |
05/28/2025 |
Sponsor Deadline: |
07/23/2025 |
Description: |
Pathway to Stop Diabetes® has a simple, yet revolutionary goal: to find scientists at the peak of their creativity and provide them with the flexibility and resources they need on the road to breakthrough discoveries. We attract and retain brilliant scientists in diabetes. Our three areas of focus—awarding research grants, providing access to scientific and career mentoring from leading diabetes researchers, and creating a diabetes think tank—are each key components of a unique formula to cultivate the next generation of leaders, whose discoveries will stop diabetes and its burdens once and for all.
To accelerate the research needed to stop this deadly disease, the American Diabetes Association’s bold transformational initiative, Pathway to Stop Diabetes®, is inspiring a new generation of diabetes researchers. Pathway provides crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention, management, and cures. We are building a human pathway to tackle the toughest questions in diabetes by driving research innovations through 1:1 mentorship and the creation of a brain trust in diabetes.
This call for nominations will prioritize translational applications that move knowledge and discovery gained from basic research to its eventual translation into patient and population benefit. The ideal applicant will propose innovative research that will be an important step towards the eventual goal of improving the lives of people at risk of diabetes or living with the disease - and the pathway to this impact is clear. Our vision is to create a pathway to launch the next generation of trailblazers in diabetes research.
ADA will accept up to two (2) nominations per institution with one (1) nomination spanning basic through preclinical research and one (1) nomination spanning clinical through public health research. |
Number of Applicants University is Allowed to submit: |
2 |
Additional Requirements: |
None |
Sponsor Guidelines: |
https://professional.diabetes.org/research-grants/current-funding-opportunities-pathway-stop-diabetes |
UM Nominations Process: |
Those interested in applying should submit the following as a single pdf document to collabor@umn.edu no later than 4pm on: 5/28/2025
1. Cover page including PI name, department, contact information, project title, any co-PI's name and department, and one paragraph project abstract. Cover page must include the award type you are applying for: Initiator or Accelerator, and whether your research would be considered 1) basic through preclinical research, or 2) clinical through public health research.
2. Project summary - to include solicitation specific information.
(not more than three pages) -
3. Biosketch of PI (2 - 5 pages, NIH, format).
4. 2-3 names of possible UMN reviewers (NOT References) (with no Conflicts of Interest) plus 5 keywords to be used as search terms for possible reviewers (can be added to Cover Page)
Any questions can be submitted to collabor@umn.edu
|
Peer Review Coordination: |
Research and Innovation Office contact email |
Status: |
The following PIs are the official UM nominees: Megan Beetch, Integrative Biology and Physiology, Sarah Wernimont, Obstetrics, Gynecology, & Women's Health |
Please note: |
To be considered for peer review and internal selection, faculty must follow the above submission guidelines and meet the UM deadline as set by the office coordinating the peer review for this opportunity. |
|
|